Our prognostic model showed that the expression of the remaining four genes (YTHDF1, YTHDF2, METTL3, and KIAA1429) was adversely associated with the prognosis of patients with HCC. This evidence concerns the gene YTHDF2 and hepatocellular carcinoma.